These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ☑ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
| ☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
|
Delaware
|
20-0709285
|
|
|
(State or other jurisdiction of Incorporation or organization)
|
(I.R.S. Employer Identification No.)
|
|
5201 Interchange Way, Louisville, KY
|
40229
|
|
|
(Address of principal executive offices)
|
(Zip Code)
|
|
Large accelerated filer
|
☐
|
Accelerated filer
|
☐
|
|
Non-accelerated filer
|
☑ (Do not check if a smaller reporting company)
|
Smaller reporting company
|
☐
|
|
Page No.
|
|||
|
PART I FINANCIAL INFORMATION
|
|||
|
ITEM 1
|
3 | ||
|
3
|
|||
|
4
|
|||
|
5
|
|||
|
6
|
|||
|
7
|
|||
|
ITEM 2
|
28
|
||
|
ITEM 3
|
40
|
||
|
ITEM 4
|
40
|
||
|
PART II OTHER INFORMATION
|
|||
|
ITEM 1
|
41
|
||
|
ITEM 1A
|
41
|
||
|
ITEM 2
|
41
|
||
|
ITEM 3
|
41
|
||
|
ITEM 4
|
41
|
||
|
ITEM 5
|
41
|
||
|
ITEM 6
|
41
|
||
|
Signature
|
42
|
||
|
43
|
|||
| PART I | FINANCIAL INFORMATION |
|
ASSETS
|
March 31,
2016
|
December 31,
2015
|
||||||
|
Current assets:
|
||||||||
|
Cash
|
$
|
2,940
|
$
|
4,835
|
||||
|
Accounts receivable, net of allowances of $137 in 2016 and 2015
|
2,649
|
3,940
|
||||||
|
Inventories
|
47,976
|
44,339
|
||||||
|
Other current assets
|
9,383
|
10,838
|
||||||
|
Total current assets
|
62,948
|
63,952
|
||||||
|
Property, plant and equipment, net
|
5,764
|
5,603
|
||||||
|
Deferred financing costs, net
|
191
|
208
|
||||||
|
Goodwill
|
128,697
|
128,697
|
||||||
|
Other intangible assets, net
|
8,553
|
8,553
|
||||||
|
Master Settlement Agreement - escrow deposits
|
31,856
|
31,842
|
||||||
|
Other assets
|
3,530
|
3,608
|
||||||
|
Total assets
|
$
|
241,539
|
$
|
242,463
|
||||
|
LIABILITIES AND STOCKHOLDERS' DEFICIT
|
||||||||
|
Current liabilities:
|
||||||||
|
Accounts payable
|
$
|
4,895
|
$
|
4,087
|
||||
|
Accrued expenses
|
9,743
|
11,053
|
||||||
|
Accrued interest expense
|
866
|
4,329
|
||||||
|
First lien term loan
|
1,650
|
1,650
|
||||||
|
Revolving credit facility
|
1,018
|
18
|
||||||
|
Total current liabilities
|
18,172
|
21,137
|
||||||
|
Notes payable and long-term debt
|
290,480
|
290,772
|
||||||
|
Deferred income taxes
|
7,054
|
7,013
|
||||||
|
Postretirement benefits
|
4,638
|
4,666
|
||||||
|
Pension benefits
|
428
|
487
|
||||||
|
Total liabilities
|
320,772
|
324,075
|
||||||
|
Commitments and contingencies
|
||||||||
|
Stockholders' deficit:
|
||||||||
|
Preferred stock; $0.01 par value; authorized shares 40,000,000; issued and outstanding shares -0-
|
||||||||
|
Common stock, voting, $0.01 par value; authorized shares, 190,000,000; issued shares, 2016 and 2015 7,312,642; outstanding shares, 2016 and 2015 6,259,480, shares held in treasury, 2016 and 2015 1,053,162
|
63
|
63
|
||||||
|
Common stock, nonvoting, $0.01 par value; authorized shares, 10,000,000; issued and outstanding shares, 2016 and 2015 938,857
|
9
|
9
|
||||||
|
Additional paid-in capital
|
12,650
|
12,628
|
||||||
|
Accumulated other comprehensive loss
|
(3,389
|
)
|
(3,512
|
)
|
||||
|
Accumulated deficit
|
(88,566
|
)
|
(90,800
|
)
|
||||
|
Total stockholders' deficit
|
(79,233
|
)
|
(81,612
|
)
|
||||
|
Total liabilities and stockholders' deficit
|
$
|
241,539
|
$
|
242,463
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Net sales
|
$
|
49,866
|
$
|
51,086
|
||||
|
Cost of sales
|
25,219
|
26,431
|
||||||
|
Gross profit
|
24,647
|
24,655
|
||||||
|
Selling, general and administrative expenses
|
13,738
|
12,671
|
||||||
|
Operating income
|
10,909
|
11,984
|
||||||
|
Interest expense and financing costs
|
8,462
|
8,482
|
||||||
|
Income before income taxes
|
2,447
|
3,502
|
||||||
|
Income tax expense
|
213
|
75
|
||||||
|
Net income
|
$
|
2,234
|
$
|
3,427
|
||||
|
Basic earnings per common share:
|
||||||||
|
Net income
|
$
|
0.31
|
$
|
0.48
|
||||
|
Diluted earnings per common share:
|
||||||||
|
Net income
|
$
|
0.27
|
$
|
0.41
|
||||
|
Weighted average common shares outstanding:
|
||||||||
|
Basic - inclusive of voting and non-voting shares
|
7,198,337
|
7,197,523
|
||||||
|
Diluted - inclusive of voting and non-voting shares
|
8,354,659
|
8,353,843
|
||||||
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Net income
|
$
|
2,234
|
$
|
3,427
|
||||
|
Other comprehensive income, net of tax -
|
||||||||
|
Pension and postretirement
|
||||||||
|
Amortization of unrealized losses recorded in cost of sales
|
6
|
6
|
||||||
|
Amortization of unrealized losses recorded in selling, general and administrative expenses
|
117
|
126
|
||||||
|
123
|
132
|
|||||||
|
Comprehensive income
|
$
|
2,357
|
$
|
3,559
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
2,234
|
$
|
3,427
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation expense
|
293
|
251
|
||||||
|
Amortization of deferred financing costs
|
362
|
362
|
||||||
|
Amortization of original issue discount
|
259
|
261
|
||||||
|
Interest incurred but not paid on PIK toggle notes
|
2,254
|
1,945
|
||||||
|
Deferred income taxes
|
41
|
(35
|
)
|
|||||
|
Stock compensation expense
|
12
|
46
|
||||||
|
Member unit compensation expense
|
10
|
29
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
1,291
|
(1,931
|
)
|
|||||
|
Inventories
|
(3,637
|
)
|
(1,742
|
)
|
||||
|
Other current assets
|
1,455
|
1,749
|
||||||
|
Other assets
|
416
|
(12
|
)
|
|||||
|
Accounts payable
|
724
|
1,159
|
||||||
|
Accrued pension liabilities
|
64
|
42
|
||||||
|
Accrued postretirement liabilities
|
(28
|
)
|
(31
|
)
|
||||
|
Accrued expenses and other
|
(4,773
|
)
|
1,322
|
|||||
|
Net cash provided by operating activities
|
977
|
6,842
|
||||||
|
Cash flows from investing activities:
|
||||||||
|
Capital expenditures
|
(454
|
)
|
(327
|
)
|
||||
|
Net cash used in investing activities
|
(454
|
)
|
(327
|
)
|
||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from revolving credit facility
|
1,000
|
93
|
||||||
|
Prepaid equity issuance costs
|
(268
|
)
|
-
|
|||||
|
Payment of first lien term loan
|
(3,150
|
)
|
(412
|
)
|
||||
|
Proceeds from issuance of stock
|
-
|
1
|
||||||
|
Net cash used in financing activities
|
(2,418
|
)
|
(318
|
)
|
||||
|
Net increase (decrease) in cash
|
(1,895
|
)
|
6,197
|
|||||
|
Cash, beginning of period
|
4,835
|
8,467
|
||||||
|
Cash, end of period
|
$
|
2,940
|
$
|
14,664
|
||||
|
Supplemental schedule of noncash financing activities:
|
||||||||
|
Accrued expenses incurred for prepaid equity costs
|
$
|
84
|
$
|
-
|
||||
|
Deposits At
|
||||||||
|
Sales
Year
|
March 31,
2016
|
December 31,
2015
|
||||||
|
1999
|
$
|
211
|
$
|
211
|
||||
|
2000
|
1,017
|
1,017
|
||||||
|
2001
|
1,673
|
1,673
|
||||||
|
2002
|
2,271
|
2,271
|
||||||
|
2003
|
4,249
|
4,249
|
||||||
|
2004
|
3,715
|
3,715
|
||||||
|
2005
|
4,552
|
4,552
|
||||||
|
2006
|
3,847
|
3,847
|
||||||
|
2007
|
4,167
|
4,167
|
||||||
|
2008
|
3,364
|
3,364
|
||||||
|
2009
|
1,626
|
1,626
|
||||||
|
2010
|
406
|
406
|
||||||
|
2011
|
193
|
193
|
||||||
|
2012
|
198
|
198
|
||||||
|
2013
|
173
|
173
|
||||||
|
2014
|
142
|
142
|
||||||
|
2015
|
52
|
38
|
||||||
|
Total
|
$
|
31,856
|
$
|
31,842
|
||||
|
March 31,
2016
|
December 31,
2015
|
|||||||
|
Raw materials and work in process
|
$
|
1,932
|
$
|
1,940
|
||||
|
Leaf tobacco
|
23,547
|
20,839
|
||||||
|
Finished goods - smokeless products
|
4,763
|
3,615
|
||||||
|
Finished goods - smoking products
|
12,498
|
14,077
|
||||||
|
Finished goods - electronic / vaporizer products
|
7,436
|
5,939
|
||||||
|
Other
|
1,417
|
1,237
|
||||||
|
51,593
|
47,647
|
|||||||
|
LIFO reserve
|
(3,617
|
)
|
(3,308
|
)
|
||||
|
$
|
47,976
|
$
|
44,339
|
|||||
|
March 31,
2016
|
December 31,
2015
|
|||||||
|
Leasehold improvements
|
$
|
2,196
|
$
|
2,196
|
||||
|
Machinery and equipment
|
9,425
|
8,997
|
||||||
|
Furniture and fixtures
|
3,147
|
3,121
|
||||||
|
14,768
|
14,314
|
|||||||
|
Accumulated depreciation
|
(9,004
|
)
|
(8,711
|
)
|
||||
|
$
|
5,764
|
$
|
5,603
|
|||||
|
March 31,
2016
|
December 31,
2015
|
|||||||
|
Accrued payroll and related items
|
$
|
4,053
|
$
|
3,659
|
||||
|
Customer returns and allowances
|
1,533
|
2,015
|
||||||
|
Other
|
4,157
|
5,379
|
||||||
|
$
|
9,743
|
$
|
11,053
|
|||||
|
March 31,
2016
|
December 31,
2015
|
|||||||
|
First Lien Term Loan
|
$
|
147,475
|
$
|
150,555
|
||||
|
Second Lien Term Loan
|
78,943
|
78,882
|
||||||
|
PIK Toggle Notes
|
61,195
|
58,882
|
||||||
|
7% Senior Notes
|
10,429
|
10,360
|
||||||
|
298,042
|
298,679
|
|||||||
|
Less deferred finance charges
|
(5,912
|
)
|
(6,257
|
)
|
||||
|
Less current maturities
|
(1,650
|
)
|
(1,650
|
)
|
||||
|
Total Notes Payable and Long-Term Debt
|
$
|
290,480
|
$
|
290,772
|
||||
|
Period
|
Maximum Ratio
|
|
Closing Date through March 31, 2015
|
6.50 to 1.00
|
|
April 1, 2015 through September 30, 2016
|
6.25 to 1.00
|
|
October 1, 2016 through September 30, 2017
|
6.00 to 1.00
|
|
October 1, 2017 through September 30, 2018
|
5.75 to 1.00
|
|
October 1, 2018 and thereafter
|
5.50 to 1.00
|
|
Period
|
Maximum Ratio
|
|
Closing Date through March 31, 2015
|
6.75 to 1.00
|
|
April 1, 2015 through September 30, 2016
|
6.50 to 1.00
|
|
October 1, 2016 through September 30, 2017
|
6.25 to 1.00
|
|
October 1, 2017 through September 30, 2018
|
6.00 to 1.00
|
|
October 1, 2018 and thereafter
|
5.75 to 1.00
|
|
Pricing Level
|
Average Excess
Availability
|
Applicable Margin for
Base Rate Loans (the
“Base Rate Margin”)
|
Applicable Margin for
LIBOR Rate Loans
(the “LIBOR Rate
Margin”)
|
|||||||
|
I
|
|
> $30,000,000
|
1.25%
|
|
2.25%
|
|
||||
|
II
|
< $30,000,000 but > $15,000,000
|
1.50%
|
|
2.50%
|
|
|||||
|
III
|
< $15,000,000
|
1.75%
|
|
2.75%
|
|
|||||
|
Issuer/
Restricted
|
Non-Restricted
|
Eliminations
|
Consolidated
|
|||||||||||||
|
ASSETS
|
||||||||||||||||
|
Current assets:
|
||||||||||||||||
|
Cash
|
$
|
953
|
$
|
1,987
|
$
|
-
|
$
|
2,940
|
||||||||
|
Accounts receivable
|
2,649
|
-
|
-
|
2,649
|
||||||||||||
|
Inventories
|
40,252
|
7,724
|
-
|
47,976
|
||||||||||||
|
Other current assets
|
6,025
|
3,358
|
-
|
9,383
|
||||||||||||
|
Total current assets
|
49,879
|
13,069
|
-
|
62,948
|
||||||||||||
|
Property, plant and equipment, net
|
5,639
|
125
|
-
|
5,764
|
||||||||||||
|
Deferred financing costs, net
|
191
|
-
|
-
|
191
|
||||||||||||
|
Goodwill
|
128,697
|
-
|
-
|
128,697
|
||||||||||||
|
Investment in subsidiaries
|
35,159
|
-
|
(35,159
|
)
|
-
|
|||||||||||
|
Other intangible assets, net
|
8,553
|
-
|
-
|
8,553
|
||||||||||||
|
Master Settlement Agreement - escrow deposits
|
31,856
|
-
|
-
|
31,856
|
||||||||||||
|
Other assets
|
3,100
|
430
|
-
|
3,530
|
||||||||||||
|
Total assets
|
$
|
263,074
|
$
|
13,624
|
$
|
(35,159
|
)
|
$
|
241,539
|
|||||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||||||||||
|
Current liabilities:
|
||||||||||||||||
|
Accounts payable
|
$
|
4,831
|
$
|
64
|
$
|
-
|
$
|
4,895
|
||||||||
|
Accrued expenses
|
8,802
|
941
|
-
|
9,743
|
||||||||||||
|
Accrued interest expense
|
866
|
-
|
-
|
866
|
||||||||||||
|
First lien term loan
|
1,650
|
-
|
-
|
1,650
|
||||||||||||
|
Revolving credit facility
|
1,018
|
-
|
-
|
1,018
|
||||||||||||
|
Total current liabilities
|
17,167
|
1,005
|
-
|
18,172
|
||||||||||||
|
Notes payable and long-term debt
|
290,480
|
-
|
-
|
290,480
|
||||||||||||
|
Deferred Income Taxes
|
7,054
|
-
|
-
|
7,054
|
||||||||||||
|
Postretirement benefits
|
4,638
|
-
|
-
|
4,638
|
||||||||||||
|
Pension benefits
|
428
|
-
|
-
|
428
|
||||||||||||
|
Total Liabilities
|
319,767
|
1,005
|
-
|
320,772
|
||||||||||||
|
Stockholders' equity (deficit):
|
||||||||||||||||
|
Common stock, voting
|
63
|
- | - |
63
|
||||||||||||
|
Common stock, non-voting
|
9
|
- | - |
9
|
||||||||||||
|
Additional paid-in capital
|
76,423
|
11,222
|
(74,995
|
)
|
12,650
|
|||||||||||
|
Advance to TPB
|
757
|
(757
|
)
|
-
|
-
|
|||||||||||
|
Accumulated other comprehensive loss
|
(3,389
|
)
|
-
|
-
|
(3,389
|
)
|
||||||||||
|
Retained earnings (accumulated deficit)
|
(130,556
|
)
|
2,154
|
39,836
|
(88,566
|
)
|
||||||||||
|
Total stockholders' equity (deficit)
|
(56,693
|
)
|
12,619
|
(35,159
|
)
|
(79,233
|
)
|
|||||||||
|
Total liabilities and stockholders' equity (deficit)
|
$
|
263,074
|
$
|
13,624
|
$
|
(35,159
|
)
|
$
|
241,539
|
|||||||
|
Issuer/
Restricted
|
Non-Restricted
|
Consolidated
|
||||||||||
|
Net sales
|
$
|
46,224
|
$
|
3,642
|
$
|
49,866
|
||||||
|
Cost of sales
|
22,706
|
2,513
|
25,219
|
|||||||||
|
Gross profit
|
23,518
|
1,129
|
24,647
|
|||||||||
|
Selling, general and administrative expenses
|
12,725
|
1,013
|
13,738
|
|||||||||
|
Operating income
|
10,793
|
116
|
10,909
|
|||||||||
|
Interest expense and financing costs
|
8,469
|
(7
|
)
|
8,462
|
||||||||
|
Income before income taxes
|
2,324
|
123
|
2,447
|
|||||||||
|
Income tax expense
|
213
|
-
|
213
|
|||||||||
|
Net income
|
$
|
2,111
|
$
|
123
|
$
|
2,234
|
||||||
|
Issuer/
Restricted
|
Non-Restricted
|
Consolidated
|
||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net income
|
$
|
2,111
|
$
|
123
|
$
|
2,234
|
||||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||
|
Depreciation expense
|
293
|
-
|
293
|
|||||||||
|
Amortization of deferred financing costs
|
362
|
-
|
362
|
|||||||||
|
Amortization of original issue discount
|
259
|
-
|
259
|
|||||||||
|
Interest incurred but not paid on PIK toggle notes
|
2,254
|
-
|
2,254
|
|||||||||
|
Deferred income taxes
|
41
|
-
|
41
|
|||||||||
|
Stock compensation expense
|
12
|
-
|
12
|
|||||||||
|
Member unit compensation expense
|
-
|
10
|
10
|
|||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Accounts receivable
|
1,179
|
112
|
1,291
|
|||||||||
|
Inventories
|
(2,187
|
)
|
(1,450
|
)
|
(3,637
|
)
|
||||||
|
Other current assets
|
(435
|
)
|
1,890
|
1,455
|
||||||||
|
Other assets
|
416
|
-
|
416
|
|||||||||
|
Accounts payable
|
709
|
15
|
724
|
|||||||||
|
Accrued pension liabilities
|
64
|
-
|
64
|
|||||||||
|
Accrued postretirement liabilities
|
(28
|
)
|
-
|
(28
|
)
|
|||||||
|
Accrued expenses and other
|
(4,617
|
)
|
(156
|
)
|
(4,773
|
)
|
||||||
|
Net cash provided by operating activities
|
433
|
544
|
977
|
|||||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Capital expenditures
|
(329
|
)
|
(125
|
)
|
(454
|
)
|
||||||
|
Net cash used in investing activities
|
(329
|
)
|
(125
|
)
|
(454
|
)
|
||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Proceeds from revolving credit facility, net
|
1,000
|
-
|
1,000
|
|||||||||
|
Prepaid equity issuance costs
|
(268
|
)
|
-
|
(268
|
)
|
|||||||
|
Payments for first lien term loan
|
(3,150
|
)
|
-
|
(3,150
|
)
|
|||||||
|
Net cash used in financing activities
|
(2,418
|
)
|
-
|
(2,418
|
)
|
|||||||
|
Net increase (decrease) in cash
|
(2,314
|
)
|
419
|
(1,895
|
)
|
|||||||
|
Cash, beginning of period
|
3,267
|
1,568
|
4,835
|
|||||||||
|
Cash, end of period
|
$
|
953
|
$
|
1,987
|
$
|
2,940
|
||||||
|
Issuer/
Restricted
|
Non-Restricted
|
Eliminations
|
Consolidated
|
|||||||||||||
|
ASSETS
|
||||||||||||||||
|
Current assets:
|
||||||||||||||||
|
Cash
|
$
|
3,267
|
$
|
1,568
|
$
|
-
|
$
|
4,835
|
||||||||
|
Accounts receivable
|
3,828
|
112
|
-
|
3,940
|
||||||||||||
|
Inventories
|
38,065
|
6,274
|
-
|
44,339
|
||||||||||||
|
Other current assets
|
5,590
|
5,248
|
-
|
10,838
|
||||||||||||
|
Total current assets
|
50,750
|
13,202
|
-
|
63,952
|
||||||||||||
|
Property, plant and equipment, net
|
5,603
|
-
|
-
|
5,603
|
||||||||||||
|
Deferred financing costs, net
|
208
|
-
|
-
|
208
|
||||||||||||
|
Goodwill
|
128,697
|
-
|
-
|
128,697
|
||||||||||||
|
Investment in subsidiaries
|
31,489
|
-
|
(31,489
|
)
|
-
|
|||||||||||
|
Other intangible assets, net
|
8,553
|
-
|
-
|
8,553
|
||||||||||||
|
Master Settlement Agreement - escrow deposits
|
31,842
|
-
|
-
|
31,842
|
||||||||||||
|
Other assets
|
3,178
|
430
|
-
|
3,608
|
||||||||||||
|
Total assets
|
$
|
260,320
|
$
|
13,632
|
$
|
(31,489
|
)
|
$
|
242,463
|
|||||||
|
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
|
||||||||||||||||
|
Current liabilities:
|
||||||||||||||||
|
Accounts payable
|
$
|
4,038
|
$
|
49
|
$
|
-
|
$
|
4,087
|
||||||||
|
Accrued expenses
|
9,956
|
1,097
|
-
|
11,053
|
||||||||||||
|
Accrued interest expense
|
4,329
|
-
|
-
|
4,329
|
||||||||||||
|
First lien term loan
|
1,650
|
-
|
-
|
1,650
|
||||||||||||
|
Revolving credit facility
|
18
|
-
|
-
|
18
|
||||||||||||
|
Total current liabilities
|
19,991
|
1,146
|
-
|
21,137
|
||||||||||||
|
Notes payable and long-term debt
|
290,772
|
-
|
-
|
290,772
|
||||||||||||
|
Deferred Income Taxes
|
7,013
|
-
|
-
|
7,013
|
||||||||||||
|
Postretirement benefits
|
4,666
|
-
|
-
|
4,666
|
||||||||||||
|
Pension benefits
|
487
|
-
|
-
|
487
|
||||||||||||
|
Total Liabilities
|
322,929
|
1,146
|
-
|
324,075
|
||||||||||||
|
Stockholders' equity (deficit):
|
||||||||||||||||
|
Common stock, voting
|
63
|
- | - |
63
|
||||||||||||
|
Common stock, non-voting
|
9
|
- | - |
9
|
||||||||||||
|
Additional paid-in capital
|
76,410
|
11,213
|
(74,995
|
)
|
12,628
|
|||||||||||
|
Advance to TPB
|
793
|
(793
|
)
|
-
|
-
|
|||||||||||
|
Accumulated other comprehensive loss
|
(3,512
|
)
|
-
|
-
|
(3,512
|
)
|
||||||||||
|
Retained earnings (accumulated deficit)
|
(136,372
|
)
|
2,066
|
43,506
|
(90,800
|
)
|
||||||||||
|
Total stockholders' equity (deficit)
|
(62,609
|
)
|
12,486
|
(31,489
|
)
|
(81,612
|
)
|
|||||||||
|
Total liabilities and stockholders' equity (deficit)
|
$
|
260,320
|
$
|
13,632
|
$
|
(31,489
|
)
|
$
|
242,463
|
|||||||
|
Issuer/
Restricted
|
Non-Restricted
|
Consolidated
|
||||||||||
|
Net sales
|
$
|
45,603
|
$
|
5,483
|
$
|
51,086
|
||||||
|
Cost of sales
|
22,999
|
3,432
|
26,431
|
|||||||||
|
Gross profit
|
22,604
|
2,051
|
24,655
|
|||||||||
|
Selling, general and administrative expenses
|
11,396
|
1,275
|
12,671
|
|||||||||
|
Operating income
|
11,208
|
776
|
11,984
|
|||||||||
|
Interest expense and financing costs
|
8,450
|
32
|
8,482
|
|||||||||
|
Income before income taxes
|
2,758
|
744
|
3,502
|
|||||||||
|
Income tax expense
|
75
|
-
|
75
|
|||||||||
|
Net income
|
$
|
2,683
|
$
|
744
|
$
|
3,427
|
||||||
|
Issuer/
Restricted
|
Non-Restricted
|
Consolidated
|
||||||||||
|
Cash flows from operating activities:
|
||||||||||||
|
Net income
|
$
|
2,683
|
$
|
744
|
$
|
3,427
|
||||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||||||
|
Depreciation expense
|
251
|
-
|
251
|
|||||||||
|
Amortization of deferred financing costs
|
362
|
-
|
362
|
|||||||||
|
Amortization of original issue discount
|
261
|
-
|
261
|
|||||||||
|
Interest incurred but not paid on PIK toggle notes
|
1,945
|
-
|
1,945
|
|||||||||
|
Deferred income taxes
|
(35
|
)
|
-
|
(35
|
)
|
|||||||
|
Stock compensation expense
|
46
|
-
|
46
|
|||||||||
|
Member unit compensation expense
|
-
|
29
|
29
|
|||||||||
|
Changes in operating assets and liabilities:
|
||||||||||||
|
Accounts receivable
|
(972
|
)
|
(959
|
)
|
(1,931
|
)
|
||||||
|
Inventories
|
(721
|
)
|
(1,021
|
)
|
(1,742
|
)
|
||||||
|
Other current assets
|
(836
|
)
|
2,585
|
1,749
|
||||||||
|
Other assets
|
(12
|
)
|
-
|
(12
|
)
|
|||||||
|
Accounts payable
|
2,153
|
(994
|
)
|
1,159
|
||||||||
|
Accrued pension liabilities
|
42
|
-
|
42
|
|||||||||
|
Accrued postretirement liabilities
|
(31
|
)
|
-
|
(31
|
)
|
|||||||
|
Accrued expenses and other
|
2,088
|
(766
|
)
|
1,322
|
||||||||
|
Net cash provided by operating activities
|
7,224
|
(382
|
)
|
6,842
|
||||||||
|
Cash flows from investing activities:
|
||||||||||||
|
Capital expenditures
|
(327
|
)
|
-
|
(327
|
)
|
|||||||
|
Issuance of note receivable
|
(800
|
)
|
800
|
-
|
||||||||
|
Net cash provided by (used in) investing activities
|
(1,127
|
)
|
800
|
(327
|
)
|
|||||||
|
Cash flows from financing activities:
|
||||||||||||
|
Proceeds from (payments of) revolving credit facility, net
|
93
|
-
|
93
|
|||||||||
|
Prepaid equity issuance costs
|
-
|
-
|
-
|
|||||||||
|
Payments for first lien term loan
|
(412
|
)
|
-
|
(412
|
)
|
|||||||
|
Issuance of stock
|
1
|
-
|
1
|
|||||||||
|
Net cash used in financing activities
|
(318
|
)
|
-
|
(318
|
)
|
|||||||
|
Net increase in cash
|
5,779
|
418
|
6,197
|
|||||||||
|
Cash, beginning of period
|
8,014
|
453
|
8,467
|
|||||||||
|
Cash, end of period
|
$
|
13,793
|
$
|
871
|
$
|
14,664
|
||||||
|
Pension Benefits
|
Postretirement Benefits
|
|||||||||||||||
|
For the three months ended March 31
|
2016
|
2015
|
2016
|
2015
|
||||||||||||
|
Service cost
|
$
|
26
|
$
|
31
|
$
|
-
|
$
|
-
|
||||||||
|
Interest cost
|
175
|
174
|
52
|
52
|
||||||||||||
|
Expected return on plan assets
|
(259
|
)
|
(295
|
)
|
-
|
-
|
||||||||||
|
Amortization of gains and losses
|
123
|
132
|
-
|
-
|
||||||||||||
|
Net periodic benefit cost
|
$
|
65
|
$
|
42
|
$
|
52
|
$
|
52
|
||||||||
|
Incentive
Shares
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Grant Date
Fair Value
|
||||||||||
|
Outstanding, December 31, 2014
|
1,692,051
|
$
|
2.17
|
$
|
1.19
|
|||||||
|
Granted
|
-
|
|||||||||||
|
Exercised
|
(1,043
|
)
|
1.06
|
0.54
|
||||||||
|
Expired
|
-
|
|||||||||||
|
Forfeited
|
(23,337
|
)
|
1.06
|
0.54
|
||||||||
|
Outstanding, December 31, 2015
|
1,667,671
|
2.19
|
1.20
|
|||||||||
|
Granted
|
-
|
|||||||||||
|
Exercised
|
-
|
|||||||||||
|
Expired
|
-
|
|||||||||||
|
Forfeited
|
(388
|
)
|
3.83
|
2.17
|
||||||||
|
Outstanding, March 31, 2016
|
1,667,283
|
$
|
2.19
|
$
|
1.21
|
|||||||
|
Unit
Options
|
Weighted
Average
Exercise
Price
|
Weighted
Average
Grant Date
Fair Value
|
||||||||||
|
Outstanding, December 31, 2014
|
1,358,889
|
$
|
1.00
|
$
|
0.25
|
|||||||
|
Granted
|
-
|
|||||||||||
|
Exercised
|
-
|
|||||||||||
|
Expired
|
-
|
|||||||||||
|
Forfeited
|
(32,047
|
)
|
1.00
|
0.25
|
||||||||
|
Outstanding, December 31, 2015
|
1,326,842
|
1.00
|
0.25
|
|||||||||
|
Granted
|
-
|
|||||||||||
|
Exercised
|
-
|
|||||||||||
|
Expired
|
-
|
|||||||||||
|
Forfeited
|
(3,990
|
)
|
1.00
|
0.25
|
||||||||
|
Outstanding, March 31, 2016
|
1,322,852
|
$
|
1.00
|
$
|
0.25
|
|||||||
|
Three Months Ended
|
||||||||||||||||||||||||
|
March 31,
|
March 31,
|
|||||||||||||||||||||||
|
2016
|
2015
|
|||||||||||||||||||||||
|
Income
|
Shares
|
Per
Share
|
Income
|
Shares
|
Per
Share
|
|||||||||||||||||||
|
Net income
|
$
|
2,234
|
$
|
3,427
|
||||||||||||||||||||
|
Basic EPS:
|
||||||||||||||||||||||||
|
Weighted average
|
7,198,337
|
$
|
0.31
|
7,197,523
|
$
|
0.48
|
||||||||||||||||||
|
Diluted EPS:
|
||||||||||||||||||||||||
|
Effect of Dilutive securities:
|
||||||||||||||||||||||||
|
Stock options and warrants
|
1,156,322
|
1,156,320
|
||||||||||||||||||||||
|
8,354,659
|
$
|
0.27
|
8,353,843
|
$
|
0.41
|
|||||||||||||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Net Sales
|
||||||||
|
Smokeless Products
|
$
|
18,339
|
$
|
17,516
|
||||
|
Smoking Products
|
27,885
|
28,087
|
||||||
|
NewGen Products
|
3,642
|
5,483
|
||||||
|
$
|
49,866
|
$
|
51,086
|
|||||
|
Operating Income
|
||||||||
|
Smokeless Products
|
$
|
3,559
|
$
|
4,523
|
||||
|
Smoking Products
|
7,540
|
6,985
|
||||||
|
NewGen Products
|
116
|
776
|
||||||
|
Other (1)
|
(156
|
)
|
(130
|
)
|
||||
|
$
|
11,059
|
$
|
12,154
|
|||||
|
Less Eliminations (2)
|
(150
|
)
|
(170
|
)
|
||||
|
$
|
10,909
|
$
|
11,984
|
|||||
|
Interest expense and financing costs
|
(8,462
|
)
|
(8,482
|
)
|
||||
|
Income before income taxes
|
$
|
2,447
|
$
|
3,502
|
||||
|
Assets
|
||||||||
|
Smokeless Products
|
$
|
77,010
|
$
|
88,045
|
||||
|
Smoking Products
|
525,233
|
495,211
|
||||||
|
NewGen Products
|
13,624
|
15,647
|
||||||
|
Other (1)
|
32,422
|
32,455
|
||||||
|
648,289
|
631,358
|
|||||||
|
Less Eliminations (2)
|
(406,750
|
)
|
(380,598
|
)
|
||||
|
$
|
241,539
|
$
|
250,760
|
|||||
| (1) | “Other” includes our assets that are not assigned to our three reportable segments, such as intercompany transfers and investments in subsidiaries. All goodwill has been allocated to our reportable segments. |
| (2) | “Elimination” includes the elimination of intercompany accounts between segments and investments in subsidiaries. |
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Domestic
|
$
|
46,974
|
$
|
48,773
|
||||
|
Foreign
|
2,892
|
2,313
|
||||||
|
Net Sales
|
$
|
49,866
|
$
|
51,086
|
||||
|
Voting shares outstanding before transactions
|
6,259,480
|
|||
|
Shares issued by the Initial Public Offering
|
6,210,000
|
|||
|
Shares issued for 7% Senior Notes
|
1,289,819
|
|||
|
Shares issued for PIK Toggle Notes
|
3,168,438
|
|||
|
Voting shares outstanding after transactions
|
16,927,737
|
|||
|
Non-Voting shares outstanding before and after transactions
|
938,857
|
|
•
|
declining sales of tobacco products, and expected continuing decline of sales, in the tobacco industry overall;
|
|
•
|
our dependence on a small number of third-party suppliers and producers;
|
|
•
|
the possibility that we will be unable to identify or contract with new suppliers or producers in the event of a supply or product disruption;
|
|
•
|
the possibility that our licenses to use certain brands or trademarks will be terminated, challenged or restricted;
|
|
•
|
failure to maintain consumer brand recognition and loyalty of our customers;
|
|
•
|
substantial and increasing U.S. regulation;
|
|
•
|
regulation of our products by the FDA;
|
|
•
|
uncertainty related to the regulation and taxation of our NewGen products;
|
|
•
|
possible significant increases in federal, state and local municipal tobacco-related taxes;
|
|
•
|
possible significant increases in tobacco-related taxes;
|
|
•
|
possible taxation of our NewGen products;
|
|
•
|
possible increasing international control and regulation;
|
|
•
|
our reliance on relationships with several large retailers and national chains for distribution of our products;
|
|
•
|
intense competition and our ability to compete effectively;
|
|
•
|
significant potential product liability litigation;
|
|
•
|
the scientific community’s lack of information regarding the long-term health effects of electronic cigarettes, vaporizer and e-liquid use;
|
|
•
|
failure to maintain and contribute significant cash amounts to an escrow account as part of a settlement agreement between us and certain U.S. states;
|
|
•
|
our substantial amount of indebtedness;
|
|
•
|
the terms of our credit facilities may restrict our current and future operations;
|
|
•
|
competition from illicit sources;
|
|
•
|
our reliance on information technology;
|
|
•
|
security and privacy breaches;
|
|
•
|
contamination of our tobacco supply or products;
|
|
•
|
infringement on our intellectual property;
|
|
•
|
third-party claims that we infringe on their intellectual property;
|
|
•
|
concentration of business with large customers;
|
|
•
|
failure to manage our growth;
|
|
•
|
fluctuations in our month-to-month results;
|
|
•
|
exchange rate fluctuations;
|
|
•
|
adverse U.S. and global economic conditions;
|
|
•
|
failure to comply with certain regulations; and
|
|
•
|
departure of key management personnel or our inability to attract and retain talent.
|
|
Actual
|
Debt Exchanged
for Equity
|
Debt Repaid
with Cash
|
Adjusted for
IPO & Conversion
|
|||||||||||||
|
Bank Debt
|
$
|
229.6
|
$
|
-
|
$
|
(20.0
|
)
|
$
|
209.6
|
|||||||
|
PIK Toggle Notes
|
62.3
|
(28.3
|
)
|
(34.0
|
)
|
-
|
||||||||||
|
7% Senior Notes
|
12.6
|
(12.6
|
)
|
-
|
-
|
|||||||||||
|
Total Debt
|
$
|
304.5
|
$
|
(40.9
|
)
|
$
|
(54.0
|
)
|
$
|
209.6
|
||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Net Sales
|
||||||||
|
Smokeless Products
|
$
|
18,339
|
$
|
17,516
|
||||
|
Smoking Products
|
27,885
|
28,087
|
||||||
|
NewGen Products
|
3,642
|
5,483
|
||||||
|
$
|
49,866
|
$
|
51,086
|
|||||
|
Operating Income
|
||||||||
|
Smokeless Products
|
$
|
3,559
|
$
|
4,523
|
||||
|
Smoking Products
|
7,540
|
6,985
|
||||||
|
NewGen Products
|
116
|
776
|
||||||
|
Other (1)
|
(156
|
)
|
(130
|
)
|
||||
|
$
|
11,059
|
$
|
12,154
|
|||||
|
Less Eliminations (2)
|
(150
|
)
|
(170
|
)
|
||||
|
$
|
10,909
|
$
|
11,984
|
|||||
|
Interest expense and financing costs
|
(8,462
|
)
|
(8,482
|
)
|
||||
|
Income before income taxes
|
$
|
2,447
|
$
|
3,502
|
||||
|
Assets
|
||||||||
|
Smokeless Products
|
$
|
77,010
|
$
|
88,045
|
||||
|
Smoking Products
|
525,233
|
495,211
|
||||||
|
NewGen Products
|
13,624
|
15,647
|
||||||
|
Other (1)
|
32,422
|
32,455
|
||||||
|
648,289
|
631,358
|
|||||||
|
Less Eliminations (2)
|
(406,750
|
)
|
(380,598
|
)
|
||||
|
$
|
241,539
|
$
|
250,760
|
|||||
| (1) | “Other” includes our assets that are not assigned to our three reportable segments, such as intercompany transfers and investments in subsidiaries. All goodwill has been allocated to our reportable segments. |
| (2) | “Elimination” includes the elimination of intercompany accounts between segments and investments in subsidiaries. |
|
•
|
Our ability to further penetrate markets with our existing products;
|
|
•
|
Our ability to introduce new products and product lines that complement our core business;
|
|
•
|
Decreasing interest in tobacco products among consumers;
|
|
•
|
Price sensitivity in our end-markets;
|
|
•
|
Marketing and promotional initiatives, which cause variability in our month-to-month results;
|
|
•
|
General economic conditions, including consumer access to disposable income;
|
|
•
|
Cost and increasing regulation of promotional and advertising activities;
|
|
•
|
Cost of complying with regulation, including newly passed “deeming regulations”;
|
|
•
|
Counterfeit and other illegal products in our end-markets; and
|
|
•
|
Currency fluctuations.
|
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Net sales
|
$
|
49,866
|
$
|
51,086
|
||||
|
Cost of sales
|
25,219
|
26,431
|
||||||
|
Gross profit
|
24,647
|
24,655
|
||||||
|
Selling, general and administrative expenses
|
13,738
|
12,671
|
||||||
|
Operating income
|
10,909
|
11,984
|
||||||
|
Interest expense and financing costs
|
8,462
|
8,482
|
||||||
|
Income before income taxes
|
2,447
|
3,502
|
||||||
|
Income tax expense
|
213
|
75
|
||||||
|
Net income
|
$
|
2,234
|
$
|
3,427
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Net income
|
$
|
2,234
|
$
|
3,427
|
||||
|
Add:
|
||||||||
|
Interest expense
|
8,462
|
8,482
|
||||||
|
Depreciation expense
|
293
|
251
|
||||||
|
Income tax expense
|
213
|
75
|
||||||
|
EBITDA
|
$
|
11,202
|
$
|
12,235
|
||||
|
Components of Adjusted EBITDA
|
||||||||
|
LIFO adjustment (a)
|
309
|
431
|
||||||
|
Pension/postretirement expense (b)
|
117
|
94
|
||||||
|
Non-cash stock option and incentives expense
|
22
|
75
|
||||||
|
Foreign exchange hedging (c)
|
(21
|
)
|
240
|
|||||
|
Warehouse reconfiguation (d)
|
-
|
375
|
||||||
|
Strategic initiatives (e)
|
432
|
363
|
||||||
|
Launch costs (f)
|
392
|
91
|
||||||
|
Adjusted EBITDA
|
$
|
12,453
|
$
|
13,904
|
||||
| (a) | Represents non-cash expense related to an inventory valuation allowance for last-in, first-out ("LIFO") reporting. |
| (b) | Represents our Pension/Postretirement expense. |
| (c) | Represents non-cash gain and loss stemming from our foreign exchange hedging activities. |
| (d) | Represents the one-time relocation of finished product for improved logistical services. |
| (e) | Represents the fees incurred for the study of strategic initatives. |
| (f) | Represents product launch costs of our new product lines. |
|
March 31,
2016
|
December 31,
2015
|
|||||||
|
Current Assets
|
$
|
62,948
|
$
|
63,952
|
||||
|
Current Liabilities
|
18,172
|
21,137
|
||||||
|
Working Capital
|
$
|
44,776
|
$
|
42,815
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Cash flows from operating activities:
|
||||||||
|
Net income
|
$
|
2,234
|
$
|
3,427
|
||||
|
Adjustments to reconcile net income to net cash provided by operating activities:
|
||||||||
|
Depreciation expense
|
293
|
251
|
||||||
|
Amortization of deferred financing costs
|
362
|
362
|
||||||
|
Amortization of original issue discount
|
259
|
261
|
||||||
|
Interest incurred but not paid on PIK toggle note
|
2,254
|
1,945
|
||||||
|
Deferred income taxes
|
41
|
(35
|
)
|
|||||
|
Stock compensation expense
|
12
|
46
|
||||||
|
Member unit compensation expense
|
10
|
29
|
||||||
|
Changes in operating assets and liabilities:
|
||||||||
|
Accounts receivable
|
1,291
|
(1,931
|
)
|
|||||
|
Inventories
|
(3,637
|
)
|
(1,742
|
)
|
||||
|
Other current assets
|
1,455
|
1,749
|
||||||
|
Other assets
|
416
|
(12
|
)
|
|||||
|
Accounts payable
|
724
|
1,159
|
||||||
|
Accrued pension liabilities
|
64
|
42
|
||||||
|
Accrued postretirement liabilities
|
(28
|
)
|
(31
|
)
|
||||
|
Accrued expenses and other
|
(4,773
|
)
|
1,322
|
|||||
|
Net cash provided by operating activities
|
$
|
977
|
$
|
6,842
|
||||
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Cash flows from investing activities:
|
||||||||
|
Capital expenditures
|
$
|
(454
|
)
|
$
|
(327
|
)
|
||
|
Net cash used in investing activities
|
$
|
(454
|
)
|
$
|
(327
|
)
|
||
|
Three Months Ended
|
||||||||
|
March 31,
2016
|
March 31,
2015
|
|||||||
|
Cash flows from financing activities:
|
||||||||
|
Proceeds from revolving credit facility borrowings
|
$
|
1,000
|
$
|
93
|
||||
|
Prepaid equity issuance costs
|
(268
|
)
|
-
|
|||||
|
Payment of first lien term loan
|
(3,150
|
)
|
(412
|
)
|
||||
|
Proceeds from issuance of stock
|
-
|
1
|
||||||
|
Net cash used in financing activities
|
$
|
(2,418
|
)
|
$
|
(318
|
)
|
||
|
March 31,
2016
|
December 31,
2015
|
|||||||
|
ABL
|
$
|
1,018
|
$
|
18
|
||||
|
First Lien Term Loan
|
147,475
|
150,555
|
||||||
|
Second Lien Term Loan
|
78,943
|
78,882
|
||||||
|
PIK Toggle Notes
|
61,195
|
58,882
|
||||||
|
7% Senior Notes
|
10,429
|
10,360
|
||||||
|
299,060
|
298,697
|
|||||||
|
Less deferred financing charges
|
(5,912
|
)
|
(6,257
|
)
|
||||
|
Less current maturities
|
(1,650
|
)
|
(1,650
|
)
|
||||
|
$
|
291,498
|
$
|
290,790
|
|||||
| PART II | OTHER INFORMATION |
| TURNING POINT BRANDS, INC. | ||||
|
By: /s/ Lawrence S. Wexler
|
||||
|
Name:
|
Lawrence S. Wexler
|
|||
| Title: |
Chief Executive Officer
|
|||
|
/s/ Mark A. Stegeman
|
||||
|
Name:
|
Mark A. Stegeman
|
|||
| Title: |
Chief Financial and Accounting Officer
|
|||
|
Dated: June 15, 2016
|
||||
|
Description
|
|
|
Second Amended and Restated Certificate of Incorporation.
|
|
|
3.2
|
Amended and Restated By-laws (incorporated by reference to Exhibit 3.3 of the Registrant’s Registration Statement on Form S-1 (File No. 333-207816) filed on November 24, 2015).
|
|
Exchange and Sale Agreement between North Atlantic Holding Company, Inc. and Standard General for PIK Notes.
|
|
|
Exchange Agreement between Turning Point Brands, Inc. and Standard General for 7% Senior Notes.
|
|
|
10.3
|
Exchange Agreement between North Atlantic Holding Company, Inc. and certain holders of the 7% Senior Notes dated November 4, 2015 (incorporated by reference to Exhibit 10.39 of the Registrant’s Registration Statement on Form S-1 (File No. 333-207816) filed on November 24, 2015).
|
|
Intrepid Brands LLC Warrant Repurchase Agreement, dated May 10, 2016.
|
|
|
Certification of Chief Executive Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a)m as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certification of Chief Financial Officer pursuant to Exchange Act Rules 13a-14(a) and 15d-14(a), as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
|
|
|
Certifications of Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|